In a move which apparently is part of Singapore Telecommunications' (SingTel) investment in new technology, the company - along with software provider Amdocs - has opened a tech development center in Israel.
In a Saturday statement pertaining to the opening of the new tech development center in partnership with Amdocs, SingTel said that voice and facial recognition will be in the initial focus area of the center, as will be systems which enhance the efficiency of mobile and Wi-Fi networks.
SingTel - the biggest telecom company in Southeast Asia - further said in its statement that its objective will be to reach out to the Israeli community of entrepreneurs for developing capabilities in key areas, together with conduct proof of concepts; and finally help the entrepreneurs commercialize them.
About SingTel's decision to open a new tech center in Israel, Allen Lew - CEO of the company's group digital life - said the company has found the wealth of talent in the country to be extremely satisfying; especially after its last-year investment in two Israeli startups, as well as its takeover of mobile advertising firm Amobee which has a technology center in Israel.
With reference to the new tech development center in Israel, Lew said that SingTel's earlier investments in Israel and the Amobee acquisition had "propelled us to open this new development center to scout for new growth engines for SingTel."
Chinese device manufacturer Lenovo officially unveiled the world's first ‘Project Tango’ Android-powered smartphone at its 2016 Tech World event this week.
The new Lenovo handset – which boasts support for Google’s Tango futuristic...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
In an apparent attempt to enhance the visual experience for Google search users carrying out...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
In an announcement made on Thursday, electric vehicle...
The Verge has revealed in a Wednesday report, citing a...
In a recently released blog post, tech biggie Google has...
In a recently-issued warning to civilian aviators, the...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).